Citing hacking risk, FDA says Hospira pump shouldn’t be used
The federal government says health care facilities should stop using Hospira’s Symbiq medication infusion pump because of its vulnerability to hacking. The Food and Drug Administration said Friday it’s the first time it has warned caregivers to stop using a product because of a cybersecurity risk. It comes at a time of rising concerns about breaches of products that connect to the Internet. Read More.